Every Form 4 that Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow FCRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FCRX filings page.
Crescent Capital BDC, Inc. president and director Henry Chung reported an open‑market purchase of 4,500 shares of common stock at $11.45 per share on May 21, 2026. Following this transaction, he directly holds 20,722 shares, including 945 shares acquired through dividend reinvestment in 2026.
Crescent Capital BDC, Inc. Chief Executive Officer Jason Breaux bought additional company stock in an open-market transaction. On May 20, 2026, he purchased 5,000 shares of Common Stock at $11.19 per share. Following this purchase, his direct holdings increased to 52,636 shares of Crescent Capital BDC, Inc. Common Stock.
Crescent Capital BDC, Inc. Chief Financial Officer Gerhard Lombard bought 1,000 shares of common stock in an open-market purchase at $11.12 per share on 2026-05-18. This is a direct ownership transaction.
After this trade, Lombard directly owns 37,373 common shares. This figure includes 2,088 shares acquired through dividend reinvestment in 2026, which were not previously reported under Rule 16a-11.